Cargando…
Observations on the Efficacy of Two Methods for the Treatment of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy
OBJECTIVE: To observe the clinical efficacy of periocular injection of triamcinolone acetonide (TA) and subpalpebral injection of botulinum toxin type A (BTXA) for the treatment of thyroid-associated ophthalmopathy (TAO) with mild unilateral upper eyelid retraction. METHOD: This was a prospective ra...
Autores principales: | Li, Dongping, Sun, Fengyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997737/ https://www.ncbi.nlm.nih.gov/pubmed/33791385 http://dx.doi.org/10.1155/2021/9514279 |
Ejemplares similares
-
Botulinum Toxin Type A Injection for Correction of Upper Eyelid Retraction in Thyroid-Associated Ophthalmopathy
por: Yang, Jing, et al.
Publicado: (2023) -
Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto’s thyroiditis and ophthalmopathy or isolated upper eyelid retraction
por: Wall, Jack R, et al.
Publicado: (2014) -
A Promising Modified Procedure for Upper Eyelid Retraction-Associated Graves’ Ophthalmopathy: Transconjunctival Lateral Levator Aponeurectomy
por: KHATAVI, Fatima, et al.
Publicado: (2017) -
Triamcinolone acetonide injection in the treatment of upper eyelid retraction in Graves’ ophthalmopathy evaluated by 3.0 Tesla magnetic resonance imaging
por: Duan, Miao, et al.
Publicado: (2022) -
Deep learning-based image analysis of eyelid morphology in thyroid-associated ophthalmopathy
por: Shao, Ji, et al.
Publicado: (2023)